Document:

Exhibit 10.2

 

SUPPLEMENT NO. 1 dated as of September 6, 2017 (this “Supplement”) to the Guarantee dated as of December 6, 2016, among each of the Guarantors listed on the signature pages thereto and any other entity that becomes a party thereto pursuant to Section 20 thereof (each such entity individually, a “Guarantor” and, collectively, the “Guarantors”), and Wells Fargo Bank, National Association, as Collateral Agent for the Secured Parties (the “Guarantee”).

 

A.                                    Reference is made to that certain Credit Agreement, dated as of the date of the Guarantee (as the same may be amended, restated, supplemented or otherwise modified, refinanced or replaced from time to time, the “Credit Agreement”), among PRA Health Sciences, Inc., a Delaware corporation (“Holdings”), Pharmaceutical Research Associates, Inc., a Virginia corporation (the “Borrower”), the lending institutions from time to time parties thereto (each a “Lender” and, collectively, the “Lenders”), Wells Fargo Bank, National Association, as Administrative Agent, Collateral Agent, Letter of Credit Issuer and Swingline Lender, and the other parties party thereto.

 

B.                                    Capitalized terms used herein and not otherwise defined herein shall have the meanings assigned to such terms in the Guarantee.

 

C.                                    The Guarantors have entered into the Guarantee in order to induce the Administrative Agent, the Collateral Agent, the Lenders, the Swingline Lender and the Letter of Credit Issuer to enter into the Credit Agreement and to induce the Lenders and the Letter of Credit Issuers to make their respective Extensions of Credit to the Borrower under the Credit Agreement and to induce one or more Cash Management Banks or Hedge Banks to enter into Secured Cash Management Agreements or Secured Hedge Agreements with Holdings and/or its Restricted Subsidiaries.

 

D.                                    Section 9.11 of the Credit Agreement and Section 20 of the Guarantee provide that additional Subsidiaries may become Guarantors under the Guarantee by execution and delivery of an instrument in the form of this Supplement.  Each undersigned Subsidiary (each a “New Guarantor”) is executing this Supplement in accordance with the requirements of the Credit Agreement to become a Guarantor under the Guarantee in order to induce the Lenders, the Swingline Lender and the Letter of Credit Issuers to make additional Extensions of Credit, to induce one or more Hedge Banks or Cash Management Banks to enter into Secured Hedge Agreements and Secured Cash Management Agreements and as consideration for Extensions of Credit previously made.

 

Accordingly, the Collateral Agent and each New Guarantor agrees as follows:

 

SECTION 1.                            In accordance with Section 20 of the Guarantee, each New Guarantor by its signature below becomes a Guarantor under the Guarantee with the same force and effect as if originally named therein as a Guarantor, and each New Guarantor hereby (a) agrees to all the terms and provisions of the Guarantee applicable to it as a Guarantor thereunder and (b) represents and warrants that the representations and warranties made by it as a Guarantor thereunder are true and correct in all material respects on and as of the date hereof (except where such representations and warranties expressly relate to an earlier date, in which case such representations and warranties were true and correct in all material respects as of such earlier date), provided that any such representation and warranty which is qualified by materiality, Material Adverse Effect or similar language is true and correct in all respects.  Each reference to a Guarantor in the Guarantee shall be deemed to include each New Guarantor.  The Guarantee is hereby incorporated herein by reference.

 

SECTION 2.                            Each New Guarantor represents and warrants to the Collateral Agent and the other Secured Parties that this Supplement has been duly authorized, executed and delivered by it and constitutes its legal, valid and binding obligation, enforceable against it in accordance with its terms,

 

 

except as enforceability thereof may be limited by bankruptcy, insolvency or other similar laws affecting creditors’ rights generally and subject to general principles of equity.

 

SECTION 3.                            This Supplement may be executed by one or more of the parties to this Supplement on any number of separate counterparts (including by facsimile or other electronic transmission), and all of said counterparts taken together shall be deemed to constitute one and the same instrument.  A set of the copies of this Supplement signed by all the parties shall be lodged with Holdings and the Collateral Agent.  This Supplement shall become effective as to each New Guarantor when the Collateral Agent shall have received counterparts of this Supplement that, when taken together, bear the signatures of such New Guarantor and the Collateral Agent.

 

SECTION 4.                            Except as expressly supplemented hereby, the Guarantee shall remain in full force and effect.

 

SECTION 5.                         THIS SUPPLEMENT AND THE RIGHTS AND OBLIGATIONS OF THE PARTIES HEREUNDER SHALL BE GOVERNED BY, AND CONSTRUED AND INTERPRETED IN ACCORDANCE WITH, THE LAW OF THE STATE OF NEW YORK.

 

SECTION 6.                            Any provision of this Supplement that is prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof and in the Guarantee, and any such prohibition or unenforceability in any jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction.  The parties hereto shall endeavor in good-faith negotiations to replace the invalid, illegal or unenforceable provisions with valid provisions the economic effect of which comes as close as possible to that of the invalid, illegal or unenforceable provisions.

 

SECTION 7.                            All notices, requests and demands pursuant hereto shall be made in accordance with Section 13.2 of the Credit Agreement.  All communications and notices hereunder to each New Guarantor shall be given to it in care of Holdings at Holdings’ address set forth in Section 13.2 of the Credit Agreement.

 

[Signature pages follow]

 

 

IN WITNESS WHEREOF, each New Guarantor and the Collateral Agent have duly executed this Supplement to the Guarantee as of the day and year first above written.

 

 

	
 
    	
SYMPHONY   HEALTH SOLUTIONS CORPORATION, as a New Guarantor
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By: 
    	
/s/ Charles H.   Munn, Jr.
    
	
 
    	
 
    	
Name: Charles H.   Munn, Jr.
    
	
 
    	
 
    	
Title: EVP, Secretary   and General Counsel
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
SOURCE   HEALTHCARE ANALYTICS, LLC, as a New Guarantor
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/ Charles H.   Munn, Jr.
    
	
 
    	
 
    	
Name: Charles H.   Munn, Jr.
    
	
 
    	
 
    	
Title: EVP, Secretary   and General Counsel
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
PARALLEL 6, INC.,   as a New Guarantor
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By: 
    	
/s/ Charles H.   Munn, Jr.
    
	
 
    	
 
    	
Name: Charles H.   Munn, Jr.
    
	
 
    	
 
    	
Title: EVP, Secretary   and General Counsel
    

 

[Signature Page to Guarantee Supplement]

 

 

	
 
    	
WELLS FARGO BANK,   NATIONAL ASSOCIATION, as the Collateral Agent
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By: 
    	
/s/ Christine Gardiner
    
	
 
    	
 
    	
Name: Christine   Gardiner
    
	
 
    	
 
    	
Title: Vice President
    

 

[Signature Page to Guarantee Supplement]Exhibit 10.3

 

SUPPLEMENT NO. 1 dated as of September 6, 2017 (this “Supplement”), to the Security Agreement dated as of December 6, 2016 (as amended, restated, supplemented or otherwise modified from time to time, the “Security Agreement”), among PRA Health Sciences, Inc., a Delaware corporation (“Holdings”), Pharmaceutical Research Associates, Inc., a Virginia corporation (the “Borrower”), each of the Subsidiaries listed on the signature pages thereto or that becomes a party thereto pursuant to Section 8.14 thereof (each such entity being a “Subsidiary Grantor” and, collectively, the “Subsidiary Grantors”; the Subsidiary Grantors, Holdings and the Borrower are referred to collectively as the “Grantors”), and Wells Fargo Bank, National Association, as collateral agent (in such capacity, the “Collateral Agent”) for the benefit of the Secured Parties.

 

A.                                    Reference is made to the Credit Agreement dated as of December 6, 2016 (as amended, restated, supplemented or otherwise modified from time to time, the “Credit Agreement”) among Holdings, the Borrower, the Lenders and agents from time to time party thereto and Wells Fargo Bank, National Association, as Administrative Agent and as Collateral Agent.

 

B.                                    Capitalized terms used herein and not otherwise defined herein shall have the meanings assigned to such terms in the Security Agreement or the Credit Agreement, as applicable.

 

C.                                    The Grantors have entered into the Security Agreement in order to induce the Administrative Agent, the Collateral Agent, the Lenders, the Swingline Lender and the Letter of Credit Issuers to enter into the Credit Agreement and to induce the Lenders to make their respective Loans, the Swingline Lender to make Swingline Loans and the Letter of Credit Issuers to issue Letters of Credit for the account of the Borrower and the Restricted Subsidiaries under the Credit Agreement and to induce one or more Lenders or Affiliates of Lenders to enter into Secured Cash Management Agreements or Secured Hedge Agreements with Holdings and/or its Subsidiaries.

 

D.                                    Section 9.11 of the Credit Agreement and Section 8.14 of the Security Agreement provide that each Subsidiary that is required to become a party to the Security Agreement pursuant to Section 9.11 of the Credit Agreement shall become a Subsidiary Grantor, with the same force and effect as if originally named as a Subsidiary Grantor therein, for all purposes of the Security Agreement upon execution and delivery by such Subsidiary of an instrument in the form of this Supplement.  Each undersigned Subsidiary (each a “New Grantor”) is executing this Supplement in accordance with the requirements of the Security Agreement to become a Subsidiary Grantor under the Security Agreement in order to induce the Lenders to make their respective Loans, the Swingline Lender to make Swingline Loans and the Letter of Credit Issuers to issue Letters of Credit for the account of the Borrower and the Restricted Subsidiaries under the Credit Agreement and to induce one or more Cash Management Banks or Hedge Banks to enter into Secured Cash Management Agreements and Secured Hedge Agreements with Holdings and/or its Subsidiaries.

 

Accordingly, the Collateral Agent and the New Grantors agree as follows:

 

SECTION 1.                            In accordance with Section 8.14 of the Security Agreement, each New Grantor by its signature below becomes a Grantor under the Security Agreement with the same force and effect as if originally named therein as a Grantor and each New Grantor hereby (a) agrees to all the terms and provisions of the Security Agreement applicable to it as a Grantor thereunder and (b) represents and warrants that the representations and warranties made by it as a Grantor thereunder are true and correct on and as of the date hereof.  In furtherance of the foregoing, each New Grantor, as security for the payment and performance in full of the Obligations, does hereby bargain, sell, convey, assign, set over, mortgage, pledge, hypothecate and transfer to the Collateral Agent for the benefit of the Secured Parties, and hereby grants to the Collateral Agent for the benefit of the Secured Parties, a Security Interest in all of the Collateral of such New Grantor, in each case whether now or hereafter existing or in which it now has or

 

1

 

hereafter acquires an interest.  Each reference to a “Grantor” in the Security Agreement shall be deemed to include each New Grantor.  The Security Agreement is hereby incorporated herein by reference.

 

SECTION 2.                            Each New Grantor represents and warrants to the Collateral Agent and the other Secured Parties that this Supplement has been duly authorized, executed and delivered by it and constitutes its legal, valid and binding obligation, enforceable against it in accordance with its terms, subject to the effects of bankruptcy, insolvency or similar laws affecting creditors’ rights generally and general equitable principles.

 

SECTION 3.                            This Supplement may be executed by one or more of the parties to this Supplement on any number of separate counterparts (including by facsimile or other electronic transmission), and all of said counterparts taken together shall be deemed to constitute one and the same instrument.  A set of the copies of this Supplement signed by all the parties shall be lodged with the Collateral Agent and Holdings.  This Supplement shall become effective as to each New Grantor when the Collateral Agent shall have received counterparts of this Supplement that, when taken together, bear the signatures of such New Grantor and the Collateral Agent.

 

SECTION 4.                            Each such New Grantor hereby represents and warrants that (a) set forth on Schedule I hereto is (i) the legal name of such New Grantor, (ii) the jurisdiction of incorporation or organization of such New Grantor, (iii) the identity or type of organization or corporate structure of such New Grantor, (iv) the Federal Taxpayer Identification Number and organizational number of such New Grantor and (v) the true and correct location of the chief executive office and principal place of business (if different to its chief executive office) and any office in which it maintains books of records relating to Collateral owned by it and (b) as of the date hereof (i) Schedule II hereto lists all of each New Grantor’s material inbound exclusive licenses in third party owned U.S. registered copyrights, (ii) Schedule III hereto lists in all material respects all of each New Grantor’s registered Copyrights (and all applications therefor), (iii) Schedule IV hereto lists all of each New Grantor’s material inbound exclusive licenses in third party owned U.S. patents and patent applications, (iv) Schedule V hereto lists in all material respects all of each New Grantor’s Patents (and all applications therefor), (v) Schedule VI hereto lists all of each New Grantor’s material inbound exclusive licenses in third party owned U.S. registered trademarks and trademark applications, (vi) Schedule VII hereto lists in all material respects all of each New Grantor’s registered Trademarks (and all applications therefor) and (vii) Schedule VIII hereto lists all of each new Grantor’s Commercial Tort Claims.

 

SECTION 5.                            Except as expressly supplemented hereby, the Security Agreement shall remain in full force and effect.

 

SECTION 6.                         THIS SUPPLEMENT AND THE RIGHTS AND OBLIGATIONS OF THE PARTIES HEREUNDER SHALL BE GOVERNED BY, AND CONSTRUED AND INTERPRETED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK.

 

SECTION 7.                            Any provision of this Supplement that is prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof and in the Security Agreement, and any such prohibition or unenforceability in any jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction.  The parties hereto shall endeavor in good faith negotiations to replace the invalid, illegal or unenforceable provisions with valid provisions the economic effect of which comes as close as possible to that of the invalid, illegal or unenforceable provisions.

 

SECTION 8.                            All notices, requests and demands pursuant hereto shall be made in accordance with Section 13.2 of the Credit Agreement.  All communications and notices hereunder to

 

 

each New Grantor shall be given to it in care of Holdings at Holdings’ address set forth in Section 13.2 of the Credit Agreement.

 

[Signature pages follow]

 

 

IN WITNESS WHEREOF, each New Grantor and the Collateral Agent have duly executed this Supplement to the Security Agreement as of the day and year first above written.

 

	
 
    	
SYMPHONY   HEALTH SOLUTIONS CORPORATION, as a New Grantor
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/ Charles H.   Munn, Jr.
    
	
 
    	
 
    	
Name: Charles H.   Munn, Jr.
    
	
 
    	
 
    	
Title: EVP, Secretary   and General Counsel
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
SOURCE   HEALTHCARE ANALYTICS, LLC, as a New Grantor
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/ Charles H.   Munn, Jr.
    
	
 
    	
 
    	
Name: Charles H.   Munn, Jr.
    
	
 
    	
 
    	
Title: EVP, Secretary and   General Counsel
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
PARALLEL 6, INC.,   as a New Grantor
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/ Charles H.   Munn, Jr.
    
	
 
    	
 
    	
Name: Charles H.   Munn, Jr.
    
	
 
    	
 
    	
Title: EVP, Secretary   and General Counsel
    

 

[Signature Page to Security Agreement Supplement]

 

 

	
 
    	
WELLS FARGO BANK,   NATIONAL ASSOCIATION, as the Collateral Agent
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/ Christine Gardiner
    
	
 
    	
 
    	
Name: Christine   Gardiner
    
	
 
    	
 
    	
Title: Vice President
    

 

[Signature Page to Security Agreement Supplement]

 

 

SCHEDULE I
 TO SUPPLEMENT NO. 1 TO THE
  SECURITY AGREEMENT

 

COLLATERAL

 

	
Legal Name
    	
 
    	
Jurisdiction of
   Incorporation or
   Organization
    	
 
    	
Type of
   Organization or
   Corporate
   Structure
    	
 
    	
Federal Taxpayer
   Identification Number
   and Organizational
   Identification
   Number
    	
 
    	
Chief Executive Office
    
	
Symphony Health Solutions Corporation
    	
 
    	
Delaware
    	
 
    	
Corporation
    	
 
    	
45-5298493
   5135791
    	
 
    	
1001 E. Hector Street
   Suite 400
   Conshohocken, PA 19428
    
	
Source Healthcare Analytics, LLC
    	
 
    	
Delaware
    	
 
    	
Limited liability company
    	
 
    	
45-4094520
   2102833
    	
 
    	
2390 E. Camelback Road
   Phoenix, AZ 85016
    
	
Parallel 6, Inc.
    	
 
    	
Delaware
    	
 
    	
Corporation
    	
 
    	
27-1283146
   4748103
    	
 
    	
Pacific Center I
   1455 Frazee Road - Suite 900
   San Diego, CA 92108
    

 

 

SCHEDULE II
 TO SUPPLEMENT NO. 1 TO THE
  SECURITY AGREEMENT

 

MATERIAL INBOUND EXCLUSIVE LICENSES IN U.S. REGISTERED COPYRIGHTS

 

None.

 

 

SCHEDULE III
 TO SUPPLEMENT NO. 1 TO THE
  SECURITY AGREEMENT

 

U.S. REGISTERED COPYRIGHTS

 

None.

 

 

SCHEDULE IV
 TO SUPPLEMENT NO.1 TO THE
  SECURITY AGREEMENT

 

MATERIAL INBOUND EXCLUSIVE LICENSES IN U.S. PATENTS AND PATENT APPLICATIONS

 

See Schedule V, as applicable.

 

 

SCHEDULE V
 TO SUPPLEMENT NO. 1 TO THE
  SECURITY AGREEMENT

 

U.S. PATENTS AND PATENT APPLICATIONS

 

Parallel 6, Inc. Patents and Patent Applications

 

	
Patent / Application
   No.
    	
 
    	
Country
    	
 
    	
Title
    	
 
    	
Application
   Status
    	
 
    	
Filing
   Date
    	
 
    	
Issue
   Date
    
	
8,856,031
    	
 
    	
US
    	
 
    	
SYSTEMS AND METHODS FOR OBTAINING AND USING TARGETED   INSIGHTS WITHIN A DIGITAL CONTENT AND INFORMATION SHARING SYSTEM
    	
 
    	
Granted; Maintenance fee due April 7 2018
    	
 
    	
11/27/2013
    	
 
    	
10/7/2014
    
	
PCT/US2014/030900
    	
 
    	
WO
    	
 
    	
SYSTEMS AND METHODS FOR OBTAINING AND USING TARGETED   INSIGHTS WITHIN A DIGITAL CONTENT AND INFORMATION SHARING SYSTEM
    	
 
    	
NAT PHASE
    	
 
    	
3/17/2014
    	
 
    	
 
    
	
2014232264
    	
 
    	
AU
    	
 
    	
SYSTEMS AND METHODS FOR OBTAINING AND USING TARGETED   INSIGHTS WITHIN A DIGITAL CONTENT AND INFORMATION SHARING SYSTEM
    	
 
    	
Pending; Annuity due March 17 2018
    	
 
    	
3/17/2014
    	
 
    	
 
    
	
2914915
    	
 
    	
CA
    	
 
    	
SYSTEMS AND METHODS FOR OBTAINING AND USING TARGETED   INSIGHTS WITHIN A DIGITAL CONTENT AND INFORMATION SHARING SYSTEM
    	
 
    	
Published; Request for Examination due March 17   2019; Annuity due March 17 2017
    	
 
    	
3/17/2014
    	
 
    	
 
    
	
201480027880.X
    	
 
    	
CN
    	
 
    	
SYSTEMS AND METHODS FOR OBTAINING AND USING TARGETED   INSIGHTS WITHIN A DIGITAL CONTENT AND INFORMATION SHARING SYSTEM
    	
 
    	
Published
    	
 
    	
3/17/2014
    	
 
    	
 
    

 

 

	
Patent / Application
   No.
    	
 
    	
Country
    	
 
    	
Title
    	
 
    	
Application
   Status
    	
 
    	
Filing
   Date
    	
 
    	
Issue
   Date
    
	
14/738,766
    	
 
    	
US
    	
 
    	
SYSTEM AND METHODS FOR MANAGING AND CONDUCTING   CLINICAL OR OTHER RESEARCH USING A DIGITAL CONTENT AND INFORMATION SHARING   SYSTEM
    	
 
    	
Final Rejection sent May 8, 2017
    	
 
    	
6/12/2015
    	
 
    	
 
    
	
14/507,735
    	
 
    	
US
    	
 
    	
SYSTEMS AND METHODS FOR OBTAINING AND USING TARGETED   INSIGHTS WITHIN A DIGITAL CONTENT AND INFORMATION SHARING SYSTEM
    	
 
    	
Published; Response to OA due January 12 2017
    	
 
    	
10/6/2014
    	
 
    	
 
    
	
14763461.2
    	
 
    	
EP
    	
 
    	
SYSTEMS AND METHODS FOR OBTAINING AND USING TARGETED   INSIGHTS WITHIN A DIGITAL CONTENT AND INFORMATION SHARING SYSTEM
    	
 
    	
Published; Annuity due March 17 2017; Response   to EESR due May 18 2017
    	
 
    	
3/17/2014
    	
 
    	
 
    
	
16109769.2
    	
 
    	
HK
    	
 
    	
SYSTEMS AND METHODS FOR OBTAINING AND USING TARGETED   INSIGHTS WITHIN A DIGITAL CONTENT AND INFORMATION SHARING SYSTEM
    	
 
    	
Pending
    	
 
    	
3/17/2014
    	
 
    	
 
    
	
2015-7029833
    	
 
    	
KR
    	
 
    	
SYSTEMS AND METHODS FOR OBTAINING AND USING TARGETED   INSIGHTS WITHIN A DIGITAL CONTENT AND INFORMATION SHARING SYSTEM
    	
 
    	
Pending; Deferred Examination due March 17 2019
    	
 
    	
3/17/2014
    	
 
    	
 
    
	
13/373,856
    	
 
    	
US
    	
 
    	
INCENTIVE-BASED DIGITAL CONTENT SHARING PLATFORM
    	
 
    	
Published; Appeal Brief due December 23 2016
    	
 
    	
12/2/2011
    	
 
    	
 
    
	
13/487,155
    	
 
    	
US
    	
 
    	
SYSTEMS AND METHODS FOR AUTOMATED INFORMED CONSENT
    	
 
    	
Final Rejection sent March 2, 2016 2016
    	
 
    	
6/1/2012
    	
 
    	
 
    
	
14/214,653
    	
 
    	
US
    	
 
    	
SYSTEMS AND METHODS FOR RECRUITING AND MATCHING   PATIENTS FOR CLINICAL TRIALS
    	
 
    	
Published; Response to OA filed 12/6/16
    	
 
    	
3/14/2014
    	
 
    	
 
    

 

 

	
Patent / Application
   No.
    	
 
    	
Country
    	
 
    	
Title
    	
 
    	
Application
   Status
    	
 
    	
Filing
   Date
    	
 
    	
Issue
   Date
    
	
15/475,088
    	
 
    	
US
    	
 
    	
SYSTEMS AND METHODS FOR REMOTE DEMAND BASED DATA   MANAGEMENT OF CLINICAL LOCATIONS
    	
 
    	
Published August 10, 2017
    	
 
    	
3/30/2017
    	
 
    	
 
    

 

Source Healthcare Analytics Patent Application

 

	
Patent
    	
 
    	
Applicant
    	
 
    	
App. No.
    	
 
    	
Filed
    	
 
    	
Status
    
	
COMPUTER IMPLEMENTED SYSTEM AND METHOD FOR   ASSOCIATING PRESCRIPTION DATA AND DE-DUPLICATION
    	
 
    	
SOURCE HEALTHCARE ANALYTICS, LLC
    	
 
    	
14/973,065
    	
 
    	
Dec. 17, 2015
    	
 
    	
Source Healthcare Analytics, LLC was assigned a   patent application no. 13/008,102, filed January 18, 2011 (published as   US 2012/0185264 A1, on July 19, 2012 (now abandoned)). A continuation of   this application was filed, no. 14/973,065, on December 17, 2015   (published as US 2016/0103976 A1, on April 14, 2016 (now pending)).
    

 

 

SCHEDULE VI
 TO SUPPLEMENT NO. 1 TO THE
  SECURITY AGREEMENT

 

MATERIAL INBOUND EXCLUSIVE LICENSES IN U.S. REGISTERED TRADEMARKS AND TRADEMARKS APPLICATIONS

 

See Schedule VII, as applicable.

 

 

SCHEDULE VII
 TO SUPPLEMENT NO. 1 TO THE
  SECURITY AGREEMENT

 

U.S. REGISTERED TRADEMARKS AND TRADEMARK APPLICATIONS

 

Parallel 6, Inc. Trademarks

 

	
Owner
    	
 
    	
Mark
    	
 
    	
App./Reg. No.
    
	
Parallel 6, Inc.
    	
 
    	
CLINICAL6 — AN MCLINICAL PLATFORM FOR PATIENT   ENROLLMENT, ENGAGEMENT, & MANAGEMENT
    	
 
    	
87/241493
    
	
Parallel 6, Inc.
    	
 
    	
CLINICAL6
    	
 
    	
87/241468
    
	
Parallel 6, Inc.
    	
 
    	
PARALLEL6
    	
 
    	
87/241454
    
	
Parallel 6, Inc.
    	
 
    	
PARALLEL6
    	
 
    	
87/241433
    
	
Parallel 6, Inc.
    	
 
    	
CLIN6
    	
 
    	
87/241,478
   ITU
    
	
Parallel 6, Inc.
    	
 
    	
NPRUV
    	
 
    	
4302736
    

 

Parallel 6, Inc. Domain Names

 

thepivotstudy.com

 

mstops.com

 

captivereach.com

 

floatiesswimschoolblog.com

 

governmentreach.com

 

parallel6.com

 

ClinicalReach.com

 

clinical6.us

 

clinical6.com

 

clinical6.info

 

clinical6.net

 

clinical6.org

 

nPruv.com

 

nPruv.net

 

nPruv.org

 

 

Symphony Health Solutions Corporation and Source Healthcare Analytics, LLC Trademarks

 

	
Mark
    	
 
    	
Owner
    	
 
    	
Country
    	
 
    	
Serial/
   Reg. No.
    	
 
    	
Status
    
	

    	
 
    	
Symphony   Health Solutions Corporation
    	
 
    	
USA
    	
 
    	
87/471,486
    	
 
    	
Pending;   filed 6/1/2017
    
	
CUSTOMERSOURCE
    	
 
    	
Symphony   Health Solutions Corporation
    	
 
    	
USA
    	
 
    	
87/424,315
    	
 
    	
Pending;   filed 4/25/2017
    
	
IDV
    	
 
    	
Symphony   Health Solutions Corporation
    	
 
    	
USA
    	
 
    	
4,770,340
    	
 
    	
Registered   7/7/2015
    
	
LAUNCHTRAC
    	
 
    	
Source   Healthcare Analytics, LLC
    	
 
    	
USA
    	
 
    	
2,197,376
    	
 
    	
Registered   10/20/1988
    
	
NONRETAILSOURCE
    	
 
    	
Symphony   Health Solutions Corporation
    	
 
    	
USA
    	
 
    	
87/424,289
    	
 
    	
Pending;   filed 4/25/2017
    
	
PATIENTSOURCE
    	
 
    	
Symphony   Health Solutions Corporation
    	
 
    	
USA
    	
 
    	
87/424,261
    	
 
    	
Pending;   filed 4/25/2017
    
	
PAYERSOURCE
    	
 
    	
Symphony   Health Solutions Corporation
    	
 
    	
USA
    	
 
    	
87/424,224
    	
 
    	
Pending;   filed 4/25/2017
    
	
PHAST
    	
 
    	
Symphony   Health Solutions Corporation
    	
 
    	
USA
    	
 
    	
87/471,438
    	
 
    	
Pending;   filed 6/1/2017
    
	
PRESCRIBER   SOURCE
    	
 
    	
Symphony   Health Solutions Corporation
    	
 
    	
USA
    	
 
    	
87/424,208
    	
 
    	
Pending;   filed 4/25/2017
    
	
SYMPHONYHEALTH   and Design 
 
    	
 
    	
Symphony   Health Solutions Corporation
    	
 
    	
USA
    	
 
    	
87/424,005
    	
 
    	
Pending;   filed 4/25/2017
    
	
SYMPHONY   HEALTH
    	
 
    	
Symphony   Health Solutions Corporation
    	
 
    	
USA
    	
 
    	
87/403,314
    	
 
    	
Pending;   filed 4/7/2017
    
	
SYMPHONY   HEALTH SOLUTIONS
    	
 
    	
Symphony   Health Solutions Corporation
    	
 
    	
European   Community
    	
 
    	
12187217
    	
 
    	
Registered   2/26/2014
    
	
SYMPHONY   HEALTH SOLUTIONS
    	
 
    	
Symphony   Health Solutions Corporation
    	
 
    	
USA
    	
 
    	
4,906,915
    	
 
    	
Registered   3/1/2016
    
	
SYMPHONY   HEALTH SOLUTIONS and Design 
    
    	
 
    	
Symphony   Health Solutions Corporation
    	
 
    	
USA
    	
 
    	
4,906,916
    	
 
    	
Registered   3/1/2016
    
	
SYMPHONY   HEALTHCLOUD
    	
 
    	
Symphony   Health Solutions Corporation
    	
 
    	
USA
    	
 
    	
5,043,542
    	
 
    	
Registered
    
	
VANTAGE
    	
 
    	
Symphony   Health Solutions Corporation
    	
 
    	
USA
    	
 
    	
86/625,690
    	
 
    	
Pending;   filed 5/11/2015; suspended
    
	
SOURCE
    	
 
    	
Source   Healthcare Analytics, LLC
    	
 
    	
USA
    	
 
    	
2,062,766
    	
 
    	
Registered   5/20/1997
    
	
TRULIFT
    	
 
    	
Symphony   Health Solutions Corporation
    	
 
    	
USA
    	
 
    	
87/505,421   ITU
    	
 
    	
Pending;   filed 6/26/2017
    
	
MEDIASTAT
    	
 
    	
Symphony   Health Solutions Corporation
    	
 
    	
USA
    	
 
    	
87/505,358   ITU
    	
 
    	
Pending;   filed 6/26/2017
    
	
PRESIGHT
    	
 
    	
Symphony   Health Solutions Corporation
    	
 
    	
USA
    	
 
    	
87/505,406   ITU
    	
 
    	
Pending;   filed 6/26/2017
    

 

 

	
Mark
    	
 
    	
Owner
    	
 
    	
Country
    	
 
    	
Serial/
   Reg. No.
    	
 
    	
Status
    
	
SYMPHONY   SPOTLIGHT
    	
 
    	
Symphony   Health Solutions Corporation
    	
 
    	
USA
    	
 
    	
87/505,327   ITU
    	
 
    	
Pending;   filed 6/26/2017
    
	
SYNOMA
    	
 
    	
Symphony   Health Solutions Corporation
    	
 
    	
USA
    	
 
    	
86/567,753   ITU
    	
 
    	
Pending;   filed 3/18/2015
    
	
SYNOMAID
    	
 
    	
Symphony   Health Solutions Corporation
    	
 
    	
USA
    	
 
    	
86/567,771   ITU
    	
 
    	
Pending;   filed 3/18/2015
    

 

Symphony Health Solutions Corporation and Source Healthcare Analytics, LLC Domain Names:

 

	
Domain Name
    	
 
    	
Expiration Date
    
	
REDHERRINGSUPPORT.COM
    	
 
    	
7/30/2019
    
	
SOURCEHEALTHCARE.NET
    	
 
    	
1/31/2019
    
	
SYMPHONYHA.CO
    	
 
    	
4/29/2018
    
	
SYMPHONYHA.MOBI
    	
 
    	
5/1/2018
    
	
SYMPHONYHEALTH.CO
    	
 
    	
6/28/2018
    
	
SYMPHONYHEALTH.COM
    	
 
    	
1/16/2019
    
	
symphonyhealth.exchange
    	
 
    	
6/23/2018
    
	
SYMPHONYHEALTH.INFO
    	
 
    	
6/29/2018
    
	
SYMPHONYHEALTH.MOBI
    	
 
    	
7/6/2018
    
	
SYMPHONYHEALTH.NET
    	
 
    	
6/29/2018
    
	
SYMPHONYHEALTH.ORG
    	
 
    	
6/29/2018
    
	
SYMPHONYHEALTH.US
    	
 
    	
7/5/2018
    
	
SYMPHONYHEALTHANALYTICS.CO
    	
 
    	
4/29/2019
    
	
SYMPHONYHEALTHANALYTICS.INFO
    	
 
    	
4/16/2018
    
	
SYMPHONYHEALTHANALYTICS.MOBI
    	
 
    	
5/1/2018
    
	
SYMPHONYHEALTHANALYTICS.ORG
    	
 
    	
4/16/2018
    
	
SYMPHONYHEALTHCLOUD.COM
    	
 
    	
1/28/2020
    
	
SYMPHONYHEALTHCLOUD.NET
    	
 
    	
1/29/2020
    
	
SYMPHONYHEALTHSOLUTIONS.BIZ
    	
 
    	
4/28/2018
    
	
SYMPHONYHEALTHSOLUTIONS.BZ
    	
 
    	
4/29/2018
    
	
SYMPHONYHEALTHSOLUTIONS.CO
    	
 
    	
4/28/2018
    
	
SYMPHONYHEALTHSOLUTIONS.INFO
    	
 
    	
4/29/2018
    
	
SYMPHONYHEALTHSOLUTIONS.MOBI
    	
 
    	
4/29/2018
    
	
SYMPHONYHEALTHSOLUTIONS.ORG
    	
 
    	
4/29/2018
    
	
SYMPHONYHEALTHSOLUTIONS.US
    	
 
    	
4/28/2018
    
	
SYMPHONYHS.CO
    	
 
    	
4/29/2018
    
	
SYMPHONYHS.MOBI
    	
 
    	
5/1/2018
    
	
SYMPHONYHS.ORG
    	
 
    	
6/11/2018
    
	
SYNOMA.BIZ
    	
 
    	
3/31/2018
    
	
SYNOMA.BZ
    	
 
    	
4/1/2018
    
	
SYNOMA.CO
    	
 
    	
3/31/2018
    
	
SYNOMA.MOBI
    	
 
    	
4/1/2018
    

 

 

	
Domain Name
    	
 
    	
Expiration Date
    
	
SYNOMA.NET
    	
 
    	
4/1/2018
    
	
SYNOMA.ORG
    	
 
    	
4/1/2018
    
	
SYNOMA.US
    	
 
    	
3/31/2018
    
	
SYNOMAANALYTICS.BIZ
    	
 
    	
3/31/2018
    
	
SYNOMAANALYTICS.BZ
    	
 
    	
4/1/2018
    
	
SYNOMAANALYTICS.CO
    	
 
    	
3/31/2018
    
	
SYNOMAANALYTICS.COM
    	
 
    	
4/1/2018
    
	
SYNOMAANALYTICS.INFO
    	
 
    	
4/1/2018
    
	
SYNOMAANALYTICS.MOBI
    	
 
    	
4/1/2018
    
	
SYNOMAANALYTICS.NET
    	
 
    	
4/1/2018
    
	
SYNOMAANALYTICS.ORG
    	
 
    	
4/1/2018
    
	
SYNOMAANALYTICS.US
    	
 
    	
3/31/2018
    
	
SYNOMAHEALTH.BIZ
    	
 
    	
3/31/2018
    
	
SYNOMAHEALTH.BZ
    	
 
    	
4/1/2018
    
	
SYNOMAHEALTH.CLOUD
    	
 
    	
7/22/2018
    
	
SYNOMAHEALTH.CO
    	
 
    	
3/31/2018
    
	
SYNOMAHEALTH.COM
    	
 
    	
4/1/2018
    
	
SYNOMAHEALTH.INFO
    	
 
    	
4/1/2018
    
	
SYNOMAHEALTH.MOBI
    	
 
    	
4/1/2018
    
	
SYNOMAHEALTH.NET
    	
 
    	
4/1/2018
    
	
SYNOMAHEALTH.ORG
    	
 
    	
4/1/2018
    
	
SYNOMAHEALTH.US
    	
 
    	
3/31/2018
    
	
SYNOMAHEALTHANALYTICS.BIZ
    	
 
    	
3/31/2018
    
	
SYNOMAHEALTHANALYTICS.BZ
    	
 
    	
4/1/2018
    
	
SYNOMAHEALTHANALYTICS.CO
    	
 
    	
3/31/2018
    
	
SYNOMAHEALTHANALYTICS.COM
    	
 
    	
4/1/2018
    
	
SYNOMAHEALTHANALYTICS.INFO
    	
 
    	
4/1/2018
    
	
SYNOMAHEALTHANALYTICS.MOBI
    	
 
    	
4/1/2018
    
	
SYNOMAHEALTHANALYTICS.NET
    	
 
    	
4/1/2018
    
	
SYNOMAHEALTHANALYTICS.ORG
    	
 
    	
4/1/2018
    
	
SYNOMAHEALTHANALYTICS.US
    	
 
    	
3/31/2018
    
	
SYNOMAHEALTHCARE.BIZ
    	
 
    	
3/31/2018
    
	
SYNOMAHEALTHCARE.BZ
    	
 
    	
4/1/2018
    
	
SYNOMAHEALTHCARE.CO
    	
 
    	
3/31/2018
    
	
SYNOMAHEALTHCARE.COM
    	
 
    	
4/1/2018
    
	
SYNOMAHEALTHCARE.INFO
    	
 
    	
4/1/2018
    
	
SYNOMAHEALTHCARE.MOBI
    	
 
    	
4/1/2018
    
	
SYNOMAHEALTHCARE.NET
    	
 
    	
4/1/2018
    
	
SYNOMAHEALTHCARE.ORG
    	
 
    	
4/1/2018
    
	
SYNOMAHEALTHCARE.US
    	
 
    	
3/31/2018
    

 

 

	
Domain Name
    	
 
    	
Expiration Date
    
	
SYNOMAHEALTHCAREANALYTICS.BIZ
    	
 
    	
3/31/2018
    
	
SYNOMAHEALTHCAREANALYTICS.BZ
    	
 
    	
4/1/2018
    
	
SYNOMAHEALTHCAREANALYTICS.CO
    	
 
    	
3/31/2018
    
	
SYNOMAHEALTHCAREANALYTICS.COM
    	
 
    	
4/1/2018
    
	
SYNOMAHEALTHCAREANALYTICS.INFO
    	
 
    	
4/1/2018
    
	
SYNOMAHEALTHCAREANALYTICS.MOBI
    	
 
    	
4/1/2018
    
	
SYNOMAHEALTHCAREANALYTICS.NET
    	
 
    	
4/1/2018
    
	
SYNOMAHEALTHCAREANALYTICS.ORG
    	
 
    	
4/1/2018
    
	
SYNOMAHEALTHCAREANALYTICS.US
    	
 
    	
3/31/2018
    
	
SYNOMAHEALTHCLOUD.COM
    	
 
    	
7/22/2018
    
	
SYNOMAHEALTHCLOUD.INFO
    	
 
    	
7/22/2018
    
	
SYNOMAHEALTHCLOUD.NET
    	
 
    	
7/22/2018
    
	
SYNOMAHEALTHCLOUD.ORG
    	
 
    	
7/22/2018
    
	
SYNOMAHEALTHCLOUD.US
    	
 
    	
7/21/2018
    
	
SYNOMAID.BIZ
    	
 
    	
3/31/2018
    
	
SYNOMAID.BZ
    	
 
    	
4/1/2018
    
	
SYNOMAID.CO
    	
 
    	
3/31/2018
    
	
SYNOMAID.COM
    	
 
    	
3/23/2018
    
	
SYNOMAID.INFO
    	
 
    	
4/1/2018
    
	
SYNOMAID.MOBI
    	
 
    	
4/1/2018
    
	
SYNOMAID.NET
    	
 
    	
4/1/2018
    
	
SYNOMAID.ORG
    	
 
    	
4/1/2018
    
	
SYNOMAID.US
    	
 
    	
3/31/2018
    
	
SYNOMANET.BIZ
    	
 
    	
3/31/2018
    
	
SYNOMANET.BZ
    	
 
    	
4/1/2018
    
	
SYNOMANET.CO
    	
 
    	
3/31/2018
    
	
SYNOMANET.COM
    	
 
    	
4/1/2018
    
	
SYNOMANET.INFO
    	
 
    	
4/1/2018
    
	
SYNOMANET.MOBI
    	
 
    	
4/1/2018
    
	
SYNOMANET.NET
    	
 
    	
4/1/2018
    
	
SYNOMANET.ORG
    	
 
    	
4/1/2018
    
	
SYNOMANET.US
    	
 
    	
3/31/2018
    

 

 

SCHEDULE VIII
 TO SUPPLEMENT NO. 1 TO THE
  SECURITY AGREEMENT

 

COMMERCIAL TORT CLAIMS

 

None.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00274-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00274-of-00352.parquet"}]]